SHARP study:Simvastatin+ezetimib versus placebo in patient with chronic kidney disease. Commentary on:Lancet 377,2011,2181-2192 +AHJ 160,2010,785-794

Abstract

Study SHARP, simvastatin, ezetimib, placebo in patients with chronic kidney diseases, influence of statins, combined treatment, cardiovascular prognosis

Keywords

• Study SHARP
• simvastatin
• ezetimib
• placebo in patients with chronic kidney diseases
• influence of statins
• combined treatment
• cardiovascular prognosis